Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions.

You can sell covered calls on INVITAE CORP to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NVTA (prices last updated Fri 4:16 PM ET):

Last Change Bid Ask Volume P/E Market Cap
13.24 +0.34 11.97 14.07 1.0M - 1.0B
Covered Calls For INVITAE CORP (NVTA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 21 12.5 1.50 12.57 -0.6% -6.1%
Mar 15 12.5 2.45 11.62 7.6% 23.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Invitae Corp. develops genetic diagnostics for hereditary disorders. It offers gene sequencing and deletion/duplication analysis for genetic disorders associated with cancer, cardiology, neurology and pediatrics. The firm is applying advances in genomics to provide clinical genetic solutions for patient, providers, and payer alike. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.